IMCD Expands its Global Pharmaceutical Innovation Network
Strengthening local expertise through a connected global platform
As the pharmaceutical industry faces increasing pressure to accelerate development timelines, navigate evolving regulations, and bring differentiated products to market, technical expertise and accessibility have become increasingly imperative.
At IMCD Pharmaceuticals, we believe the future of pharmaceutical partnerships lies at the intersection of market intelligence, formulation expertise, technical support, and global collaboration. This vision is driving continued investment in our worldwide Pharmaceutical Technical Centre (PTC) network, including new facilities in Istanbul, Türkiye; New Jersey, United States; and Mexico City, Mexico. These additions further strengthen a connected global innovation ecosystem designed to help customers move from concept to commercialisation with greater speed and confidence.
More than distribution: IMCD's unique position in the pharmaceutical market
Many organisations can supply ingredients. Few can combine global market insight, technical formulation expertise, regulatory understanding, supplier partnerships, and local customer support within a single integrated model.
IMCD occupies a unique position between ingredient manufacturers and pharmaceutical developers. Through our technical centres, we bridge the gap between innovative raw materials and real-world formulation challenges, helping customers identify opportunities, solve technical hurdles, and develop differentiated pharmaceutical products.
Our teams are involved throughout the innovation journey, from formulation development and optimisation, technical troubleshooting and technology transfer, analytical characterisation and performance evaluation, to training and knowledge transfer as well as regulatory and commercialisation support through the development of value-added and patient-centric formulations.
Building a truly global pharmaceutical innovation network
IMCD's pharmaceutical technical infrastructure has grown into one of the industry's most extensive distributor-led laboratory networks, comprising of eight Pharmaceutical Technical Centres and a dedicated quality laboratory connected globally through a digital collaboration platform.
IMCD’s global PTC network spans:
- Cologne, Germany
- Mumbai, India
- Jakarta, Indonesia
- Shanghai, China
- São Paulo, Brazil
- New Jersey, USA
- Istanbul, Türkiye
- Mexico City, Mexico
- Seoul, South Korea (QL)
Supported by more than 50 technical experts worldwide, these centres function as a single knowledge-sharing ecosystem, allowing insights generated in one region to be rapidly transferred and adapted across global markets.
Istanbul: Connecting Europe, the Middle East, and Central Asia
The opening of the Pharmaceutical Technical Centre in Istanbul represents a strategic milestone for IMCD Pharmaceuticals.
Situated at the crossroads of Europe and Asia, Istanbul is uniquely positioned to support customers across Türkiye, the Middle East, North Africa, and neighbouring growth markets. The new facility enhances local access to formulation development, technical training, troubleshooting support, and customer collaboration programmes, bringing expertise closer to pharmaceutical manufacturers operating in these fast-growing regions.
New Jersey: Expanding support in one of the world's leading pharmaceutical hubs
The expansion of IMCD's technical presence in the United States reinforces our commitment to serving one of the most influential pharmaceutical markets globally.
Located in the heart of a major pharmaceutical innovation corridor, the New Jersey facility enhances collaboration with customers, suppliers, and development partners seeking advanced formulation support and accelerated product development.
Mexico City: Building a bridge between South and North America
Following IMCD's expansion in the region, Mexico has become a strategic hub connecting global innovation with the growing pharmaceutical and nutraceutical industries throughout Latin America.
Through its local technical resources, regulatory understanding, and close customer collaboration, IMCD Mexico helps accelerate formulation development and commercial success in one of the region's most dynamic healthcare markets.
Beyond geographic reach, these centres strengthen IMCD's ability to respond to region-specific formulation challenges while maintaining direct access to the expertise and resources of the broader global network. Customers benefit from local engagement backed by global knowledge, creating a powerful model for pharmaceutical innovation and market responsiveness.
Technical excellence that drives commercial success
What differentiates IMCD's Pharmaceutical Technical Centres is not simply the equipment or laboratory infrastructure. It is the way technical expertise is combined with market understanding and customer collaboration.
Across the network, scientific teams develop innovative concepts, perform application testing, conduct formulation studies, create technical publications, deliver customer training, and support troubleshooting throughout the product lifecycle. The centres also enable close collaboration with suppliers, academic partners, and customers to translate emerging trends into commercially viable pharmaceutical solutions.
This approach has already helped customers overcome manufacturing challenges, optimise formulations, achieve bioequivalence targets, implement advanced delivery technologies, and accelerate product launches across multiple global markets.
Ready for the future of pharmaceuticals
As pharmaceutical innovation continues to evolve, IMCD remains committed to investing in the capabilities that matter most to customers.
Through a growing global network of Pharmaceutical Technical Centres, connected expertise, digital collaboration, and deep formulation know-how, IMCD is creating a future-ready platform that helps pharmaceutical manufacturers innovate faster, reduce development risk, and bring differentiated therapies to market.
IMCD Pharmaceuticals: Advancing ideas for a healthy future.